RE:I tell people about this stock curing cancer no side effectsYeah, it would be nice to see a sustained higher price. But I guess at the moment without seeing the numbers that come out of a Phase 2 trial, investors just are not yet convinced. Successfully treating the small number of bladder cancer patients in Phase 1 does not mean that the same results of 100% efficacy will be seen in the larger Phase 2 clinical trials.
I am hanging onto my shares but don't really expect much of a sustained uptick in the SP until Phase 2 clinical trial results are released and are favorable. I hope one day we will be rewarded for our patience. We shall see.